First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments

Assessment of the Usual Choice for a First-line Treatment in Case of Atrial Fibrillation : Comparison Between Cardiology Department and Geriatric Unit.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02884661

Acronym

ACFA

Enrollment

100

Registered

2016-08-31

Start date

2015-10-31

Completion date

2015-12-31

Last updated

2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

In order to evaluate the implementation for the recommendations about the patient care for atrial fibrillation in aged patients, a non-interventional study is performed retrospectively by comparing two approach of the focus in Cardiology Department and in Geriatric unit.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

75 Years to No maximum

Healthy volunteers

Inclusion criteria

* having an atrial fibrillation * cared in Cardiology department or in geriatric unit

Exclusion criteria

* having a mitral valvulopathy, or a valvular disease with a surgery indication * having a valvular prosthesis * history of valve reconstruction

Design outcomes

Primary

Measure	Time frame
Implementation of the recommendations about non-valvular atrial fibrillation	September 1st, 2014 to October 13, 2015

Secondary

Measure	Time frame
Etiologic factors of the atrial fibrillations	September 1st, 2014 to October 13, 2015
Use of supplementary examinations	September 1st, 2014 to October 13, 2015
Use of a standard geriatric assessment	September 1st, 2014 to October 13, 2015
Socio-demographic data	September 1st, 2014 to October 13, 2015
Choice of the anti-thrombosis treatment	September 1st, 2014 to October 13, 2015
Choice of the anti-arrhythmia treatment	September 1st, 2014 to October 13, 2015
Use of an assessment of the risks of thrombosis and bleeding	September 1st, 2014 to October 13, 2015

Countries

France

Outcome results